Subscribe to Newsletter

Santen Pharmaceuticals

Content by Santen Pharmaceuticals:

Articles

Business & Profession Glaucoma

Quest for the Ideal Bleb

| Sponsored by Santen Pharmaceuticals | 9 min read

Why Santen’s PRESERFLO MicroShunt could mean “fewer sleepless nights for glaucoma surgeons”

Subspecialties Glaucoma

Relieving The Pressure, With PRESERFLO

| Sponsored by Santen Pharmaceuticals | 6 min read

Glaucoma expert Julián García Feijóo shares their experiences with the PRESERFLO MicroShunt

Business & Profession Business and Innovation

Sustainability: A Message from Siân Boisseau

| Sponsored by Santen Pharmaceuticals | 2 min read

Santen Pharmaceutical’s Siân Boisseau shares the company’s vision for achieving sustainability in eye care

Subspecialties Glaucoma

An Update on Glaucoma Surgery

| Sponsored by Santen Pharmaceuticals

Early glaucoma surgery may be the best option for some patients – but which procedure to choose, for which patients, and when?

Subspecialties Glaucoma

GlaucomaFest: Accelerating Innovation Across Medical Education in Ophthalmology

| Sponsored by Santen Pharmaceuticals

GlaucomaFest: the first of its kind in medical education, providing a brand new, immersive virtual experience for ophthalmologists in Europe

COVID-19 and Dry Eye Disease

| Sponsored by Santen Pharmaceuticals

Stefano Barabino explains how the pandemic is affecting ocular surface health

Subspecialties Glaucoma

Glaucoma Surgery: Consistent Outcomes Are Now in Your Hands

| Sponsored by Santen Pharmaceuticals

Is PRESERFLO™ MicroShunt a viable and predictable alternative to trabeculectomy?

Subspecialties Retina

Gene Therapies: A Visionary Modality

| Sponsored by Santen Pharmaceuticals

Ophthalmology is now ready to embrace gene therapy technologies that promise a stream of novel products for unmet medical needs

Subspecialties Business and Innovation

Pushing Boundaries with Advanced Technologies

| Sponsored by Santen Pharmaceuticals

How are technological innovations shaping the present – and future – of ophthalmology?

Subspecialties Glaucoma

Glaucoma: Building a New Future with AI

| Sponsored by Santen Pharmaceuticals

Is artificial intelligence tomorrow’s answer to screening, management, and treatment? Experts weigh in.

Webinars on Demand

Subspecialties Glaucoma

Target Pressure and 24-hour IOP control

| Sponsored by Santen Pharmaceuticals

This webinar aims to support the effective management of glaucoma across the whole 24 hours of the day.

Subspecialties Glaucoma

Practical Approaches in the Diagnosis and Treatment of Glaucoma

| Sponsored by Santen Pharmaceuticals

This webinar provides an overview on the latest developments in diagnosis and management of glaucoma.

Subspecialties Glaucoma

Updates in medical and surgical management of glaucoma

| Sponsored by Santen Pharmaceuticals

This webinar will discuss updated target IOP algorithms in the treatment of glaucoma

Subspecialties Cornea / Ocular Surface

Can we improve compliance and treatment success in medical therapy of glaucoma?

| Sponsored by Santen Pharmaceuticals

This webinar is sponsored by Santen and will discuss the role of compliance in medical therapy of glaucoma

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: